Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t (9; 17)(q22; q11)

I Panagopoulos, M Mencinger, CU Dietrich… - Oncogene, 1999 - nature.com
I Panagopoulos, M Mencinger, CU Dietrich, B Bjerkehagen, G Saeter, F Mertens, N Mandahl…
Oncogene, 1999nature.com
Although most extraskeletal myxoid chondrosarcomas (EMC) are cytogenetically
characterized by the translocation t (9; 22)(q22; q12), another subset has recently been
identified carrying at (9; 17)(q22; q11). Whereas the t (9; 22) is known to result in fusion of
the CHN (TEC) gene from 9q22 with the EWS gene from 22q12, creating a chimeric
EWS/CHN, the genes involved in the t (9; 17) of EMC are unknown. We examined two EMC
with t (9; 17)(q22; q11) and found that the CHN gene was recombined with the RBP56 gene …
Abstract
Although most extraskeletal myxoid chondrosarcomas (EMC) are cytogenetically characterized by the translocation t (9; 22)(q22; q12), another subset has recently been identified carrying at (9; 17)(q22; q11). Whereas the t (9; 22) is known to result in fusion of the CHN (TEC) gene from 9q22 with the EWS gene from 22q12, creating a chimeric EWS/CHN, the genes involved in the t (9; 17) of EMC are unknown. We examined two EMC with t (9; 17)(q22; q11) and found that the CHN gene was recombined with the RBP56 gene from 17q11 to generate a chimeric RBP56/CHN. RBP56 has not previously been shown to be involved in tumorigenesis but it encodes a putative RNA-binding protein similar to the EWS and FUS (TLS) proteins known to play a pathogenetic role in several sarcomas. The presence of the RBP56/CHN chimeric gene in EMC with t (9; 17)(q22; q11) shows that the N-terminal parts of EWS and RBP56 have similar oncogenic potential making them pathogenetically equivalent in oncoproteins arising from fusions with certain transcription factors.
nature.com